“The President’s announcement reflects the reality that pharmacy benefit manager (PBM) tactics are exploding Americans’ prescription drug costs, and this action is an attempt to strike a blow against the PBMs’ manipulation and self-enrichment in the prescription drug supply chain."
FDA declined to issue guidance or rulemaking, which CRN said will stifle innovation and perpetuate conflict between supplement makers and pharmaceutical companies.
A cleaner option for families.
Indomethacin is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of several painful and inflammatory conditions.
The US is the largest market for APIs, fueled by high drug use, strong regulation, and top biotech manufacturing.
Starting October 5, more than 150 new items inspired by the hit series will be available in Target stores and online.
5 gum is teaming up with global music sensation KATSEYE to deliver sensorial experiences that capture 'how it feels to chew 5 gum'.
"Meet the Retailers" and "Meet the Wholesalers" are twinned programs that are part of PLMA's popular PLMA Live! Lunch and Learn online speaker series.
The campaign spotlights the Masterpiece Collection, crafted to delight a new generation of chocolate lovers.
The state-of-the-art forward distribution center will feature automation and the latest technology advancements in support of the segment's distribution of more than 70,000 pharmaceutical and specialty deliveries daily across the United States.
Brand also launches two limited-time NERDS Gummy Clusters flavors just in time for football season.
Millions of deals and exclusive holiday savings for Prime members.
"The Door has been an extraordinary partner with the NRF Foundation in expanding access to retail careers to young people in New York City."
The new system aims to make shopping easier and more independent for guests with disabilities.
A prolonged government shutdown would result in significant disruptions to health care funding and oversight.
AbbVie said the site will be fully operational by 2027, enabling API production for select European and Asian products in the U.S.
